Neurology

The data, which comes less than a month after the FDA granted RMAT designation, highlighted…

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Joel Salinas, MD,…

Most treatment-emergent adverse events for patients on UB-312 were mild or moderate, and comparable to…

Overall, treated patients showed improvements in multiple cardiac measures, including left ventricular ejection fraction, as…

Panelists share their approaches to counseling adult patients with spinal muscular atrophy (SMA) about treatment…

Key opinion leaders share their strategies for discussing potential changes in therapy and transitioning between…

Neal K. Shah, CEO of CareYaya Health Technologies, discussed the groundbreaking potential of AI-powered music…

The chief executive officer and the chief scientific officer at CureDuchenne talked about a recent…

Catch up on any of the neurology news headlines you may have missed over the…

Here's some of what is coming soon to NeurologyLive® this week.: Source: Neurology Read More